Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.
Glicksman RM, Metser U, Vines D, Valliant J, Liu Z, Chung PW, Bristow RG, Finelli A, Hamilton R, Fleshner NE, Perlis N, Zlotta AR, Green D, Bayley A, Helou J, Raman S, Kulkarni G, Catton C, Lam T, Chan R, Warde P, Gospodarowicz M, Jaffray DA, Berlin A. Glicksman RM, et al. Eur Urol. 2021 Sep;80(3):374-382. doi: 10.1016/j.eururo.2021.02.031. Epub 2021 Mar 6. Eur Urol. 2021. PMID: 33685838 Clinical Trial.
Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer.
Anconina R, Ortega C, Metser U, Liu ZA, Suzuki C, McInnis M, Darling GE, Wong R, Taylor K, Yeung J, Chen EX, Swallow CJ, Bajwa J, Jang RW, Elimova E, Veit-Haibach P. Anconina R, et al. Among authors: liu za. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1012-1020. doi: 10.1007/s00259-021-05514-w. Epub 2021 Sep 7. Eur J Nucl Med Mol Imaging. 2022. PMID: 34491404
Anal Adenocarcinoma: A Rare Entity in Need of Multidisciplinary Management.
Lukovic J, Kim JJ, Liu ZA, Cummings BJ, Brierley JD, Wong RKS, Ringash JG, Dawson LA, Barry A, Krzyzanowska MK, Chen EX, Hedley DW, Quereshy FA, Swallow CJ, Gryfe RN, Kennedy ED, Easson AM, Hosni A. Lukovic J, et al. Among authors: liu za. Dis Colon Rectum. 2022 Feb 1;65(2):189-197. doi: 10.1097/DCR.0000000000002281. Dis Colon Rectum. 2022. PMID: 34990422
Impact of Definitive Chemoradiation on Quality-of-Life Changes for Patients With Anal Cancer: Long-term Results of a Prospective Study.
Hosni A, Ringash J, Han K, Liu ZA, Brierley JD, Wong RKS, Dawson LA, Cummings BJ, Krzyzanowska MK, Chen EX, Hedley D, Knox JJ, Easson AM, Lindsay P, Craig T, Kim J. Hosni A, et al. Among authors: liu za. Dis Colon Rectum. 2022 May 1;65(5):642-653. doi: 10.1097/DCR.0000000000002385. Dis Colon Rectum. 2022. PMID: 35067501
Combined 18 F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer.
Anconina R, Ortega C, Metser U, Liu ZA, Elimova E, Allen M, Darling GE, Wong R, Taylor K, Yeung J, Chen EX, Swallow CJ, Jang RW, Veit-Haibach P. Anconina R, et al. Among authors: liu za. Clin Nucl Med. 2022 Aug 1;47(8):684-691. doi: 10.1097/RLU.0000000000004253. Epub 2022 May 11. Clin Nucl Med. 2022. PMID: 35543637
Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis.
Barry AS, Helou J, Bezjak A, Wong R, Dawson LA, Ringash J, Fazelzad R, Liu Z, Olson R, Palma D, Ost P, Siva S, Phillips R, Adhikari NKJ. Barry AS, et al. Radiother Oncol. 2022 Aug;173:163-169. doi: 10.1016/j.radonc.2022.05.033. Epub 2022 Jun 6. Radiother Oncol. 2022. PMID: 35680076
Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up.
Dmytriw AA, Ortega C, Anconina R, Metser U, Liu ZA, Liu Z, Li X, Sananmuang T, Yu E, Joshi S, Waldron J, Huang SH, Bratman S, Hope A, Veit-Haibach P. Dmytriw AA, et al. Among authors: liu z, liu za. Cancers (Basel). 2022 Jun 24;14(13):3105. doi: 10.3390/cancers14133105. Cancers (Basel). 2022. PMID: 35804877 Free PMC article.
Patient-Reported and Clinical Outcomes From 5-Fraction SBRT for Oligometastases: A Prospective Single-Institution Study.
Wong RKS, Liu ZA, Barry A, Rogalla P, Bezjak A, Brierley JD, Dawson LA, Giuliani M, Kim J, Ringash J, Sun A, Chung P, Hope A, Shessel A, Lindsay P. Wong RKS, et al. Among authors: liu za. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):1000-1010. doi: 10.1016/j.ijrobp.2022.07.025. Epub 2022 Jul 25. Int J Radiat Oncol Biol Phys. 2022. PMID: 35901981 Free article.
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.
Glicksman RM, Ramotar M, Metser U, Chung PW, Liu Z, Vines D, Finelli A, Hamilton R, Fleshner NE, Perlis N, Zlotta AR, Bayley A, Helou J, Raman S, Kulkarni G, Catton C, Lam T, Chan R, Warde P, Gospodarowicz M, Jaffray DA, Berlin A. Glicksman RM, et al. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):693-704. doi: 10.1016/j.ijrobp.2022.06.080. Epub 2022 Aug 27. Int J Radiat Oncol Biol Phys. 2022. PMID: 36031465 Clinical Trial.
309 results